Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Deighan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 16, 2005
A cognitive behavioral group approach to enhance adherence to hemodialysis fluid restrictions: a randomized controlled trialJohn Sharp, Matt R Wild, Andrew I Gumley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 29, 2005
Factors predicting outcome in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiographySamira Siddiqui, Mark S MacGregor, Catherine Glynn, et al.
Atherosclerosis|January 20, 2009
Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuriaSamira Bell, Josephine Cooney, Christopher J Packard, et al.
Nephron. Clinical Practice|May 30, 2008
Endothelial function in patients with proteinuric primary glomerulonephritisBruce Mackinnon, Christopher J Deighan, William R Ferrell, et al.
Clinical Nephrology|May 19, 2012
The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuriaSamira Bell, Josephine Cooney, Christopher J Packard, et al.
Journal of the American Society of Nephrology : JASN|July 26, 2002
Early initiation of dialysis fails to prolong survival in patients with end-stage renal failureJamie P Traynor, Keith Simpson, Colin C Geddes, et al.
Nephron. Clinical Practice|July 15, 2005
A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failureMark S MacGregor, Christopher J Deighan, R Stuart C Rodger, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2001
Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal diseaseChristopher J Deighan, Muriel J Caslake, Michael McConnell, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 19, 2010
Assessing proteinuria in chronic kidney disease: protein-creatinine ratio versus albumin-creatinine ratioShona Methven, Mark S MacGregor, Jamie P Traynor, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 19, 2010
Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKDShona Methven, Mark S MacGregor, Jamie P Traynor, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 16, 2005
A cognitive behavioral group approach to enhance adherence to hemodialysis fluid restrictions: a randomized controlled trialJohn Sharp, Matt R Wild, Andrew I Gumley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 29, 2005
Factors predicting outcome in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiographySamira Siddiqui, Mark S MacGregor, Catherine Glynn, et al.
Atherosclerosis|January 20, 2009
Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuriaSamira Bell, Josephine Cooney, Christopher J Packard, et al.
Nephron. Clinical Practice|May 30, 2008
Endothelial function in patients with proteinuric primary glomerulonephritisBruce Mackinnon, Christopher J Deighan, William R Ferrell, et al.
Clinical Nephrology|May 19, 2012
The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuriaSamira Bell, Josephine Cooney, Christopher J Packard, et al.
Journal of the American Society of Nephrology : JASN|July 26, 2002
Early initiation of dialysis fails to prolong survival in patients with end-stage renal failureJamie P Traynor, Keith Simpson, Colin C Geddes, et al.
Nephron. Clinical Practice|July 15, 2005
A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failureMark S MacGregor, Christopher J Deighan, R Stuart C Rodger, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2001
Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal diseaseChristopher J Deighan, Muriel J Caslake, Michael McConnell, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 19, 2010
Assessing proteinuria in chronic kidney disease: protein-creatinine ratio versus albumin-creatinine ratioShona Methven, Mark S MacGregor, Jamie P Traynor, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 19, 2010
Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKDShona Methven, Mark S MacGregor, Jamie P Traynor, et al.
Pageof 2